GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Standard BioTools Inc (NAS:LAB) » Definitions » Cyclically Adjusted PB Ratio

Standard BioTools (Standard BioTools) Cyclically Adjusted PB Ratio : 1.08 (As of May. 02, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Standard BioTools Cyclically Adjusted PB Ratio?

As of today (2024-05-02), Standard BioTools's current share price is $2.55. Standard BioTools's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $2.36. Standard BioTools's Cyclically Adjusted PB Ratio for today is 1.08.

The historical rank and industry rank for Standard BioTools's Cyclically Adjusted PB Ratio or its related term are showing as below:

LAB' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.33   Med: 1.08   Max: 3.15
Current: 1.08

During the past years, Standard BioTools's highest Cyclically Adjusted PB Ratio was 3.15. The lowest was 0.33. And the median was 1.08.

LAB's Cyclically Adjusted PB Ratio is ranked better than
68.18% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.975 vs LAB: 1.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Standard BioTools's adjusted book value per share data for the three months ended in Dec. 2023 was $-1.845. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.36 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Standard BioTools Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Standard BioTools's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard BioTools Cyclically Adjusted PB Ratio Chart

Standard BioTools Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.24 1.88 1.23 0.40 0.94

Standard BioTools Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.69 0.72 1.14 0.94

Competitive Comparison of Standard BioTools's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Standard BioTools's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Standard BioTools's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Standard BioTools's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Standard BioTools's Cyclically Adjusted PB Ratio falls into.



Standard BioTools Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Standard BioTools's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.55/2.36
=1.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Standard BioTools's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Standard BioTools's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.845/129.4194*129.4194
=-1.845

Current CPI (Dec. 2023) = 129.4194.

Standard BioTools Quarterly Data

Book Value per Share CPI Adj_Book
201403 5.976 99.695 7.758
201406 5.747 100.560 7.396
201409 5.474 100.428 7.054
201412 5.307 99.070 6.933
201503 4.961 99.621 6.445
201506 4.613 100.684 5.930
201509 4.312 100.392 5.559
201512 3.984 99.792 5.167
201603 3.425 100.470 4.412
201606 2.902 101.688 3.693
201609 2.334 101.861 2.965
201612 1.823 101.863 2.316
201703 1.314 102.862 1.653
201706 0.814 103.349 1.019
201709 1.012 104.136 1.258
201712 0.798 104.011 0.993
201803 1.248 105.290 1.534
201806 0.890 106.317 1.083
201809 0.570 106.507 0.693
201812 1.462 105.998 1.785
201903 2.642 107.251 3.188
201906 2.488 108.070 2.980
201909 2.338 108.329 2.793
201912 2.196 108.420 2.621
202003 2.001 108.902 2.378
202006 1.862 108.767 2.216
202009 2.051 109.815 2.417
202012 1.865 109.897 2.196
202103 1.640 111.754 1.899
202106 1.437 114.631 1.622
202109 1.299 115.734 1.453
202112 1.230 117.630 1.353
202203 0.286 121.301 0.305
202206 -0.476 125.017 -0.493
202209 -0.792 125.227 -0.819
202212 -1.025 125.222 -1.059
202303 -1.235 127.348 -1.255
202306 -1.433 128.729 -1.441
202309 -1.657 129.860 -1.651
202312 -1.845 129.419 -1.845

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Standard BioTools  (NAS:LAB) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Standard BioTools Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Standard BioTools's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Standard BioTools (Standard BioTools) Business Description

Traded in Other Exchanges
Address
2 Tower Place, Suite 2000, South San Francisco, CA, USA, 94080
Standard BioTools Inc manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. The company's segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Executives
Martin D Madaus director 290 CONCORD ROAD, BILLERICA MA 01821
Jeffrey G. Black officer: SVP & Chief Financial Officer 4955 DIRECTORS PLACE, SAN DIEGO CA 92121
Eli Casdin director, 10 percent owner 1350 AVENUE OF THE AMERICAS, SUITE 1140, NEW YORK NY 10019
Casdin Partners Master Fund, L.p. director, 10 percent owner WALKER HOUSE, 87 MARY STREET, GEORGE TOWN E9 KY1-9001
Casdin Partners Fo1-msv, Lp director C/O CASDIN PARTNERS GP, LLC, 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Casdin Private Growth Equity Fund Ii Gp, Llc director 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Casdin Partners Gp, Llc director, 10 percent owner 1350 AVENUE OF THE AMERICAS, SUITE 1140, NEW YORK NY 10019
Casdin Capital, Llc director, 10 percent owner 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Casdin Private Growth Equity Fund Ii, L.p. director 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Fenel M Eloi director C/O INTERLEUKIN GENETICS INC, 135 BEAVER STREET, WALTHAM MA 02452
Caligan Partners Lp 10 percent owner 515 MADISON AVENUE, 8TH FLOOR, NEW YORK NY 10022
Frank Witney director 940 WINTER STREET, C/O PERKINELMER, WALTHAM MA 02451
Jeremy Steven Davis officer: SVP Chief Commercial Officer C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, SUITE 2000, SOUTH SAN FRANCISCO CA 94080
Hanjoon Alex Kim officer: Chief Operating Officer C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, SUITE 2000, SOUTH SAN FRANCISCO CA 94080
Michael Egholm director, officer: President & CEO 1 FRANKLIN STREET, UNIT 3104, BOSTON MA 02110